Pashayan N - Search Results

1

Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.

Sud A, Thomsen H, Orlando G, Försti A, Law PJ, Broderick P, Cooke R, Hariri F, Pastinen T, Easton DF, Pharoah PDP, Dunning AM, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N, Campa D; PRACTICAL Consortium; Hoffmann P, Nöthen MM, Jöckel KH, von Strandmann EP, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS. Sud A, et al. Among authors: pashayan n. Blood. 2018 Nov 8;132(19):2040-2052. doi: 10.1182/blood-2018-06-855296. Epub 2018 Sep 7. Blood. 2018. PMID: 30194254 Free PMC article.

2

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment.

Herzog C, Jones A, Evans I, Zikan M, Cibula D, Harbeck N, Colombo N, Rådestad AF, Gemzell-Danielsson K, Pashayan N, Widschwendter M. Herzog C, et al. Among authors: pashayan n. NPJ Precis Oncol. 2023 Sep 27;7(1):99. doi: 10.1038/s41698-023-00452-2. NPJ Precis Oncol. 2023. PMID: 37758816 Free PMC article.

3

A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population.

Mbuya-Bienge C, Pashayan N, Kazemali CD, Lapointe J, Simard J, Nabi H. Mbuya-Bienge C, et al. Among authors: pashayan n. Cancers (Basel). 2023 Nov 12;15(22):5380. doi: 10.3390/cancers15225380. Cancers (Basel). 2023. PMID: 38001640 Free PMC article. Review.

4

PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression.

Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW. Pashayan N, et al. Int J Cancer. 2011 Mar 15;128(6):1462-70. doi: 10.1002/ijc.25471. Int J Cancer. 2011. PMID: 20499312 Free article. Clinical Trial.

5

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.

Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, Easton DF, Eeles R, Pharoah P. Pashayan N, et al. Br J Cancer. 2011 May 10;104(10):1656-63. doi: 10.1038/bjc.2011.118. Epub 2011 Apr 5. Br J Cancer. 2011. PMID: 21468051 Free PMC article.

6

Translating genomics into improved population screening: hype or hope?

Pashayan N, Pharoah P. Pashayan N, et al. Hum Genet. 2011 Jul;130(1):19-21. doi: 10.1007/s00439-011-0985-x. Epub 2011 Apr 12. Hum Genet. 2011. PMID: 21484433 No abstract available.

7

Population-based screening in the era of genomics.

Pashayan N, Pharoah P. Pashayan N, et al. Per Med. 2012 Jun;9(4):451-455. doi: 10.2217/pme.12.40. Per Med. 2012. PMID: 22984365 Free PMC article.

8

Stratified cancer screening: the practicalities of implementation.

Dent T, Jbilou J, Rafi I, Segnan N, Törnberg S, Chowdhury S, Hall A, Lyratzopoulos G, Eeles R, Eccles D, Hallowell N, Pashayan N, Pharoah P, Burton H. Dent T, et al. Among authors: pashayan n. Public Health Genomics. 2013;16(3):94-9. doi: 10.1159/000345941. Epub 2013 Jan 26. Public Health Genomics. 2013. PMID: 23363703

9

What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?

Hall AE, Chowdhury S, Pashayan N, Hallowell N, Pharoah P, Burton H. Hall AE, et al. Among authors: pashayan n. J Med Ethics. 2014 Mar;40(3):163-7. doi: 10.1136/medethics-2012-101079. Epub 2013 Mar 1. J Med Ethics. 2014. PMID: 23454719

10

Public health implications from COGS and potential for risk stratification and screening.

Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Burton H, et al. Among authors: pashayan n. Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582. Nat Genet. 2013. PMID: 23535723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page